## First-Line Medical Management of BPH with LUTS **Key Point:** Alpha-1 adrenergic antagonists (α-blockers) are the first-line pharmacological agents for symptomatic BPH with LUTS in the absence of acute retention or significant obstruction. ### Mechanism of Action Tamsulosin and other α-blockers (doxazosin, terazosin, alfuzosin) work by blocking α1A-adrenergic receptors on the smooth muscle of the prostate and bladder neck, leading to: - Relaxation of prostatic smooth muscle - Improved urinary flow within weeks - Rapid symptom relief (onset: 2–4 weeks) ### Why Tamsulosin First? | Feature | α-Blocker (Tamsulosin) | 5α-Reductase Inhibitor (Finasteride) | |---------|------------------------|---------------------------------------| | **Onset of action** | 2–4 weeks | 3–6 months | | **Symptom relief** | Rapid | Slow | | **Prostate shrinkage** | Minimal | 20–30% reduction | | **Indications** | All LUTS patients | Prostate >40 g, PSA >1.4 ng/mL | | **First-line** | Yes | No (second-line or combination) | **High-Yield:** In this patient with moderate LUTS (peak flow 8 mL/s, PVR 45 mL) but no acute retention, α-blockers provide rapid symptom improvement and are the standard initial choice. ### When to Add or Switch to Finasteride - Prostate volume >40 g on ultrasound - PSA >1.4 ng/mL - Risk of progression (age >60, baseline PSA >1.4) - Combination therapy (finasteride + α-blocker) reduces symptom progression by ~34% vs. α-blocker alone **Clinical Pearl:** Tamsulosin is preferred over non-selective α-blockers (doxazosin, terazosin) because it has uroselective action on α1A receptors in the prostate, causing fewer systemic side effects (hypotension, dizziness). ### Dosing - **Tamsulosin:** 0.4 mg once daily (can increase to 0.8 mg if needed) - **Finasteride:** 5 mg once daily (requires 3–6 months for full effect) [cite:Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.